Showing results (301-310 of 374) with videos related to
Sort By:
Pageof 38
Advances in Radiation Oncology|November 9, 2017
The impact of different stereotactic radiation therapy regimens for brain metastases on local control and toxicityRachel B Jimenez, Brian M Alexander, Anand Mahadevan, et al.Neuro-Oncology|August 7, 2008
Oxidative response gene polymorphisms and risk of adult brain tumorsPreetha Rajaraman, Amy Hutchinson, Nathaniel Rothman, et al.International Journal of Radiation Oncology, Biology, Physics|March 10, 2001
Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysisH H Pai, A Thornton, L Katznelson, et al.Neuro-Oncology Practice|August 7, 2019
Temozolomide therapy for aggressive functioning pituitary adenomas refractory to surgery and radiation: a case seriesJustin T Jordan, Julie J Miller, Tucker Cushing, et al.Neurosurgery|July 23, 2019
Brachytherapy as an Adjuvant for Recurrent Atypical and Malignant MeningiomasMatthew J Koch, Pankaj K Agarwalla, Trevor J Royce, et al.International Journal of Radiation Oncology, Biology, Physics|June 5, 2007
Patient study of in vivo verification of beam delivery and range, using positron emission tomography and computed tomography imaging after proton therapyKatia Parodi, Harald Paganetti, Helen A Shih, et al.Neuro-Oncology|July 24, 2014
Significance of targeted therapy and genetic alterations in EGFR, ALK, or KRAS on survival in patients with non-small cell lung cancer treated with radiotherapy for brain metastasesKimberley S Mak, Justin F Gainor, Andrzej Niemierko, et al.Journal of the National Cancer Institute|December 19, 1990
Results of stereotactic brachytherapy used in the initial management of patients with glioblastomaJ S Loeffler, E Alexander, P Y Wen, et al.Journal of Neuroimmunology|January 4, 2011
Selected human leukocyte antigen class II polymorphisms and risk of adult gliomaBryan A Bassig, Peter D Inskip, Laurie Burdette, et al.Practical Radiation Oncology|May 1, 2018
The role of proton beam therapy in central neurocytoma: A single-institution experienceKylie H Kang, Emily Schapira, Andrzej Niemierko, et al.Pageof 38